In conclusion, these data taken together indicate that (1) the presence of wt p53 associated with a normal downstream pRB pathway is an important characteristic which render cancer cells very sensitive to drugs inhibiting ribosome biogenesis and (2) cancer cells with RB1 loss could be sensitive to ribosome biogenesis inhibitors irrespective of the p53 status. This evidence concerns the gene RB1 and cancer.